Published in Telemedicine Business Week, September 21st, 2005
Results from MS-325-12 and MS-325-13 were published in the July and September 2005 issues of the journal Radiology. The articles indicate that MS-325, a contrast agent designed specifically for vascular imaging with magnetic resonance angiography (MRA), provides higher quality images of the aortoiliac vessels resulting in better agreement with x-ray angiography, the standard of reference, than noncontrast MRA. MS-325 is being codeveloped by...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Telemedicine Business Week